SK413591A3 - Substituted androsta-1,4-diene 3,17-diones,method of their production and use and pharmaceutical agent - Google Patents

Substituted androsta-1,4-diene 3,17-diones,method of their production and use and pharmaceutical agent Download PDF

Info

Publication number
SK413591A3
SK413591A3 SK4135-91A SK413591A SK413591A3 SK 413591 A3 SK413591 A3 SK 413591A3 SK 413591 A SK413591 A SK 413591A SK 413591 A3 SK413591 A3 SK 413591A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
diene
dione
hydrogen
Prior art date
Application number
SK4135-91A
Other languages
English (en)
Slovak (sk)
Inventor
Franco Buzzetti
Natale Barbugian
Paolo Lombardi
Salle Enrico Di
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10582036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK413591(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SK413591A3 publication Critical patent/SK413591A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK4135-91A 1985-07-09 1991-12-30 Substituted androsta-1,4-diene 3,17-diones,method of their production and use and pharmaceutical agent SK413591A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517360A GB8517360D0 (en) 1985-07-09 1985-07-09 Substituted androsta-1,4-diene-3,17-diones

Publications (1)

Publication Number Publication Date
SK413591A3 true SK413591A3 (en) 1995-07-11

Family

ID=10582036

Family Applications (1)

Application Number Title Priority Date Filing Date
SK4135-91A SK413591A3 (en) 1985-07-09 1991-12-30 Substituted androsta-1,4-diene 3,17-diones,method of their production and use and pharmaceutical agent

Country Status (38)

Country Link
US (2) US4808616A (OSRAM)
JP (1) JPS6212797A (OSRAM)
KR (1) KR950003614B1 (OSRAM)
CN (1) CN86104664B (OSRAM)
AT (1) AT395157B (OSRAM)
AU (1) AU578840B2 (OSRAM)
BE (1) BE905067A (OSRAM)
BG (1) BG61370B2 (OSRAM)
BR (1) BR1100240A (OSRAM)
CA (1) CA1277656C (OSRAM)
CH (1) CH668599A5 (OSRAM)
CS (2) CS258498B2 (OSRAM)
CZ (1) CZ413591A3 (OSRAM)
DE (1) DE10199030I1 (OSRAM)
DK (1) DK163520C (OSRAM)
ES (2) ES8801304A1 (OSRAM)
FI (1) FI83424C (OSRAM)
FR (1) FR2584725B1 (OSRAM)
GB (2) GB8517360D0 (OSRAM)
GR (1) GR861780B (OSRAM)
HK (1) HK94190A (OSRAM)
HU (1) HU194274B (OSRAM)
IE (1) IE58949B1 (OSRAM)
IL (1) IL79336A (OSRAM)
IT (1) IT1196436B (OSRAM)
MY (1) MY102294A (OSRAM)
NL (2) NL193616C (OSRAM)
NO (2) NO165547C (OSRAM)
NZ (1) NZ216763A (OSRAM)
PH (1) PH21785A (OSRAM)
PT (1) PT82944B (OSRAM)
SE (1) SE468988B (OSRAM)
SG (1) SG80490G (OSRAM)
SK (1) SK413591A3 (OSRAM)
SU (2) SU1442077A3 (OSRAM)
UA (1) UA6046A1 (OSRAM)
YU (2) YU44585B (OSRAM)
ZA (1) ZA865079B (OSRAM)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
AU652038B2 (en) * 1991-03-28 1994-08-11 Teikoku Hormone Mfg. Co., Ltd. Novel oxa- or azasteroid derivative
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
AU665455B2 (en) * 1992-09-30 1996-01-04 Teikoku Hormone Mfg. Co., Ltd. Novel 7-substituted oxa- or azasteroid compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
WO2001004342A1 (en) * 1999-07-07 2001-01-18 Pharmacia & Upjohn Company Process to prepare exemestane
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia
GB0005257D0 (en) * 2000-03-03 2000-04-26 Pharmacia & Upjohn Spa Breast cancer hormonal therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0017635D0 (en) * 2000-07-18 2000-09-06 Pharmacia & Upjohn Spa Antitumor combined therapy
EP1322333A2 (en) * 2000-08-09 2003-07-02 Pharmacia Italia S.p.A. Composition for combined use of aromatase inhibitors
BR0113625A (pt) * 2000-09-08 2003-07-22 Pharmacia Italia Spa Exemestano como agente de quimioprevenção
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
ES2269682T3 (es) * 2001-01-26 2007-04-01 Pfizer Italia S.R.L. Exemestano para tratar transtornos que dependen de hormonas.
EP2762140B1 (en) 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
CA2444867C (en) 2001-05-16 2010-08-17 Novartis Ag Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
US20040043938A1 (en) * 2001-11-06 2004-03-04 Dinesh Purandare Combination therapy for estrogen-dependent disorders
GB0128510D0 (en) * 2001-11-28 2002-01-23 Novartis Ag Organic compounds
BR0311173A (pt) 2002-05-16 2005-03-15 Novartis Ag Uso de agentes de ligação do receptor de edg em câncer
CN1304413C (zh) * 2002-10-24 2007-03-14 上海华拓医药科技发展有限公司 一种抗癌药物依西美坦制备方法
CN1317293C (zh) * 2002-10-24 2007-05-23 南京长澳医药科技有限公司 一种依西美坦的合成工艺
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
WO2005070951A1 (en) * 2004-01-16 2005-08-04 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
CN101312743A (zh) 2005-09-30 2008-11-26 安德西有限公司 (s)-6-甲基氧杂烷基依西美坦化合物及相关使用方法
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
NZ572299A (en) 2006-05-09 2010-07-30 Novartis Ag Combination comprising a substituted 3,5-diphenyl-1,2,4-triazole and a platinum compound and use thereof
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
NZ591955A (en) 2007-10-16 2011-10-28 Repros Therapeutics Inc Trans-clomiphene for diabetes mellitus type 2
EP2070943A1 (en) * 2007-12-14 2009-06-17 Crystal Pharma, S.A. Process for obtaining 6-Alkylidenandrost-1,4-diene-3one
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
US8288571B2 (en) * 2008-01-21 2012-10-16 Cadila Healthcare Limited Process for preparing aromatiase inhibitor exemestane
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
WO2010076811A2 (en) * 2008-12-30 2010-07-08 Ind-Swift Laboratories Limited Process for the preparation of exemestane
ES2587977T3 (es) 2009-05-01 2016-10-28 Celloxess Llc Tratamiento de la infertilidad masculina secundaria al estrés oxidativo de esperma
RU2425052C1 (ru) * 2010-03-04 2011-07-27 Татьяна Степановна Савинова Способ получения 6-метиленандрост-4-ен-3,17-диона из андрост-4-ен-3,17-диона, способ получения 6-метиленандроста-1,4-диен-3,17-диона (эксеместана) с использованием полученного 6-метиленандрост-4-ен-3,17-диона
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
JP2013525296A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー 内分泌療法抵抗性乳癌の処置
ES2605960T3 (es) 2010-09-14 2017-03-17 Endece, Llc Derivados de desmetil-estradiol 6-sustituido como agonistas del RE-beta
EP2819676B1 (en) 2012-02-29 2018-05-30 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
JP2017505345A (ja) 2014-02-11 2017-02-16 ノバルティス アーゲー がんの処置のためのｐｉ３ｋ阻害剤を含む組合せ医薬
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (OSRAM) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US3112305A (en) * 1960-11-07 1963-11-26 British Drug Houses Ltd 6-methylene-3-oxo-delta4-steroids and process for their preparation
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
BE759143A (fr) * 1969-11-19 1971-05-19 Upjohn Co Procede de preparation d'un nouveau compose steroide
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
AU5979986A (en) 1987-01-15
AU578840B2 (en) 1988-11-03
YU44585B (en) 1990-10-31
PT82944A (en) 1986-08-01
CH668599A5 (de) 1989-01-13
DE10199030I1 (de) 2001-10-04
BE905067A (fr) 1987-01-08
CN86104664A (zh) 1987-02-18
ZA865079B (en) 1987-03-25
FR2584725B1 (fr) 1988-05-13
UA6046A1 (uk) 1994-12-29
ES8802429A1 (es) 1988-06-01
CN86104664B (zh) 1988-06-29
GB8517360D0 (en) 1985-08-14
IE861821L (en) 1987-01-09
US4904650A (en) 1990-02-27
BG61370B2 (bg) 1997-06-30
NO862753D0 (no) 1986-07-08
IT8621004A0 (it) 1986-07-02
CS258498B2 (en) 1988-08-16
YU44628B (en) 1990-10-31
SU1501923A3 (ru) 1989-08-15
GB2177700B (en) 1988-12-07
NL300017I2 (nl) 2001-01-02
SG80490G (en) 1990-11-23
YU120186A (en) 1988-02-29
FI862871A0 (fi) 1986-07-07
ES556550A0 (es) 1987-12-16
DK324386D0 (da) 1986-07-08
IT1196436B (it) 1988-11-16
FI862871A7 (fi) 1987-01-10
NL8601785A (nl) 1987-02-02
ES557466A0 (es) 1988-06-01
NZ216763A (en) 1988-05-30
GR861780B (en) 1986-11-11
CA1277656C (en) 1990-12-11
DK163520B (da) 1992-03-09
MY102294A (en) 1992-05-15
FR2584725A1 (fr) 1987-01-16
DK324386A (da) 1987-01-10
NL193616C (nl) 2000-04-04
NO2000009I1 (no) 2000-10-05
BR1100240A (pt) 1999-12-28
FI83424B (fi) 1991-03-28
SU1442077A3 (ru) 1988-11-30
CZ413591A3 (en) 1994-03-16
CS257794B2 (en) 1988-06-15
HK94190A (en) 1990-11-23
JPH0443919B2 (OSRAM) 1992-07-20
SE8603046D0 (sv) 1986-07-08
GB8616585D0 (en) 1986-08-13
ATA181986A (de) 1992-02-15
NO862753L (no) 1987-01-12
IE58949B1 (en) 1993-12-01
GB2177700A (en) 1987-01-28
JPS6212797A (ja) 1987-01-21
CS521486A2 (en) 1987-09-17
FI83424C (fi) 1991-07-10
NO165547C (no) 1991-02-27
NL193616B (nl) 1999-12-01
DK163520C (da) 1992-07-27
HU194274B (en) 1988-01-28
IL79336A (en) 1991-06-10
SE8603046L (sv) 1987-01-10
PH21785A (en) 1988-02-24
PT82944B (pt) 1989-01-30
YU103687A (en) 1988-08-31
NO165547B (no) 1990-11-19
ES8801304A1 (es) 1987-12-16
SE468988B (sv) 1993-04-26
IL79336A0 (en) 1986-10-31
AT395157B (de) 1992-10-12
KR870001140A (ko) 1987-03-11
US4808616A (en) 1989-02-28
KR950003614B1 (ko) 1995-04-17
HUT42780A (en) 1987-08-28
NL300017I1 (nl) 2000-11-01

Similar Documents

Publication Publication Date Title
SK413591A3 (en) Substituted androsta-1,4-diene 3,17-diones,method of their production and use and pharmaceutical agent
EP0269574B1 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
US5583239A (en) Antimicrobial sterol conjugates
GB1591934A (en) Cyclosporin derivatives
US20100120736A1 (en) Mineralocorticoid Receptor Antagonists
JPS62142198A (ja) 新規中間体
EP0688785A2 (en) Manufacture of catechol estrogens derivatives
JPS6323895A (ja) 新規な６−もしくは７−メチレンアンドロスタ−１，４−ジエン−３，１７−ジオン誘導体およびその製造方法
PL138796B1 (en) Process for preparing novel 6 alpha-methylcorticoids
CA2171740C (en) 0rally active derivatives of 1,3,5(10)-estratriene
US3200114A (en) 17-tetrahydropyranyl ethers of (3, 2-c)-pyrazole and (2, 3-d)-isoxazole derivatives o the androstane and 19-norandrostane series
JPS62158300A (ja) １０β−アルキニルエストレン誘導体およびそれらの製造法
NO168481B (no) 14,17beta-ethano-14beta-oestratrienderivater, befruktningshindrende middel, og anvendelse derav for befruktningskontroll hos kvinner.
US4241064A (en) 9H-Pyrido[3,4-b]indole derivatives
US3980638A (en) Testosterone derivatives
JPS63280094A (ja) ３−メチレン−４−アンドロステン−１７−オン、その製造法、および該化合物を含有する、エストロゲン生合成阻止作用および受胎能変更作用を有する医薬
JP4277015B2 (ja) ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物
EP0193871B1 (en) 2-oxa- or aza-pregnane compounds
US3254099A (en) 17alpha-substituted-17beta-hydroxy androstane and androstene derivatives
US3225072A (en) Carbalkoxyhydrazones of the androstane series
US3743660A (en) 17-sulfo-acetates of estradiol
US4140700A (en) D-Homopregnanes
Gardner et al. New contraceptive agents with high activity in rats
NZ207413A (en) Steroid intermediates in the preparation of 24,24-difluoro-25-hydroxy-vitamin d3
NO822565L (no) 2-cyanosteroider.